Opioid Hazard Smothers Drug Shares – The Wall Street Journal

Even good company earnings just cannot reverse trader angst in excess of drug organizations going through opioid litigation threat.

Generics producer Teva Pharmaceutical Industries was the newest to practical experience that. Gross sales of $4.three billion and modified earnings of 60 cents a share the two topped analysts’ expectations. Teva also reaffirmed its whole-year direction.


Examine A lot more

Add Comment